- Visibility 56 Views
- Downloads 52 Downloads
- Permissions
- DOI 10.18231/j.ijced.67329.1758875654
-
CrossMark
- Citation
A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin
Introduction: Dermatophytosis is a common superficial fungal infection affecting keratinized tissues, with significant health and cosmetic impacts. Though itraconazole is widely used due to its broad-spectrum antifungal efficacy, its higher cost and adverse effects necessitate exploration of alternatives like ultramicrosized griseofulvin. This study aimed to compare the clinical efficacy, safety, and cost-effectiveness of oral itraconazole and oral ultramicrosized griseofulvin in the treatment of tinea corporis and tinea cruris.
Materials and Methods: A randomized controlled trial was conducted over 24 months at Era’s Lucknow Medical College & Hospital. A total of 243 patients with KOH-confirmed tinea corporis or tinea cruris were randomly allocated into two groups: Group A (n=121) received oral itraconazole 100 mg twice daily, and Group B (n=122) received oral ultramicrosized griseofulvin 500 mg twice daily for six weeks. Clinical, mycological, and symptomatic evaluations were performed at baseline and at 2, 4, 6, and 8 weeks. p-values <0.05 considered statistically significant.
Results: Both groups were comparable in baseline demographic and clinical characteristics. Among the 88 patients receiving itraconazole and 83 receiving ultramicrosized griseofulvin, recurrence rates were comparable. At 8 weeks, scaling resolution was significantly higher with Itraconazole (97.0% vs 76.9%), while erythema and pruritus showed similar improvement across groups. Recurrence rates and KOH negativity were comparable between groups. No adverse events necessitating treatment withdrawal were reported in either group.
Conclusion: Ultramicrosized griseofulvin is a safe, cost-effective, and clinically effective alternative to itraconazole for treating dermatophytosis, particularly in low-resource settings.
References
- Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8(2):240–59.
- Jartarkar SR, Patil A, Goldust Y, Cockerell CJ, Schwartz RA, Grabbe R, et al. Pathogenesis, immunology and management of dermatophytosis. J Fungi (Basel). 2021;8(1):39.
- Dismukes WE, Pappas PG, Sobel JD. Clinical mycology. New York: Oxford University Press; 2003.
- Al-Janabi AA. Dermatophytosis: causes, clinical features, signs and treatment. J Sympt Signs. 2014;3(3):200–3.
- Bitew A. Dermatophytosis: prevalence of dermatophytes and non- dermatophyte fungi from patients attending Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. Dermatol Res Pract. 2018;2018:8164757.
- Bontems O, Fratti M, Salamin K, Guenova E, Monod M. Epidemiology of dermatophytoses in Switzerland according to a survey of dermatophytes isolated in Lausanne between 2001 and
- J Fungi (Basel). 2020;6(2):95.
- Brasch J, Glaser R. Dynamic diversity of dermatophytes. Hautarzt. 2019;70(8):575–80.
- Ferguson L, Fuller LC. Spectrum and burden of dermatophytes in children. J Infect. 2017;74(Suppl 1):S54–60.
- Gandhi S, Patil S, Patil S, Badad A. Clinicoepidemiological study of dermatophyte infections in pediatric age group at a tertiary hospital in Karnataka. Indian J Paediatr Dermatol. 2019;20(1):52–
- Bhatia VK, Sharma PC. Epidemiological studies on dermatophytosis in human patients in Himachal Pradesh, India. Springerplus. 2014;3:134.
- Araya S, Abuye M, Negesso AE. Epidemiological characterization of dermatomycosis in Ethiopia. Clin Cosmet Investig Dermatol. 2021;14:83–9.
- Elsner P, Hartmann AA, Kohlbeck M. Dermatophytoses in Würzburg 1976–1985. Mykosen. 1987;30:584–8.
- Tietz HJ, Kunzelmann V, Schoenian G. Changes in the fungal spectrum of dermatomycoses. Mycoses. 1995;38(Suppl 1):33-39.
- Patro N, Panda M, Jena AK. The menace of superficial dermatophytosis on the quality of life of patients attending referral hospital in Eastern India: a cross-sectional observational study. Indian Dermatol Online J. 2019;10(3):262–6.
- Narang T, Bhattacharjee R, Singh S, Jha K, Kavita, Mahajan R, Dogra S. Quality of life and psychological morbidity in patients with superficial cutaneous dermatophytosis. Mycoses. 2019;62(8):680–5.
- Yee G, Al Aboud AM. Tinea corporis. [Updated 2021 Jan 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
- Available fro m: https://www.ncbi.nlm.nih.gov/books/NBK544360/
- De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs. 2001;61(Suppl 1):27–37.
- Kurn H, Wadhwa R. Itraconazole. [Updated 2023 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
- Available from: https://www.ncbi.nlm.nih.gov/books/NBK557874/
- Elewski B, Tavakkol A. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag. 2005;1(4):299–306.
- Abraham AO, Panda PK. Itraconazole induced congestive heart failure: a case study. Curr Drug Saf. 2018;13(1):59-61.
- Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32(12):2264–74.
- Lachapelle JM, De Doncker P, Tennstedt D, Cauwenbergh G, Janssen PA. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manuum: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology. 1992;184(1):45–50.
- Panagiotidou D, Kousidou T, Chaidemenos G, Karakatsanis G, Kalogeropoulou A, Teknetzis A, et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study. J Int Med Res. 1992;20(5):392–400.
- López-Gómez S, Del Palacio A, Van Cutsem J, Cuétara MS, Iglesias L, Rodriguez-Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol. 1994;33(10):743–7.
- Ramesh A, Devasena S, Mathew D. Efficacy and safety of oral terbinafine with itraconazole or griseofulvin combination therapy in the management of dermatophytosis: a randomised clinical trial. J Clin Diagn Res. 2022;16(1):WC05–8.
- Acharya KM, Mukhopadhyay A, Thakur RK, Mehta T, Bhuptani N, Patel R. Itraconazole versus griseofulvin in the treatment of tinea corporis and tinea cruris. Indian J Dermatol Venereol Leprol. 1995;61(4):209–211.
- Van BT, Em DV, Anh NL, Hang DTN, Nhung VH, Tuan PV. Comparison of itraconazole and griseofulvin for treatment of tinea corporis in Bac Ninh Dermatology Hospital. J 108 Clin Med Pharm. 2021;15:26–30.
- Stolmeier DA, Stratman HB, McIntee TJ, Stratman EJ. Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections. JAMA Dermatol. 2018;154(12):1409–16.
- Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol. 2001;18(5):433–8.
- Olson JM, Troxell T. Griseofulvin. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
- Available from: https://www.ncbi.nlm.nih.gov/books/NBK537323/
How to Cite This Article
Vancouver
Singh A, Saxena K, Kalawat R, . K, Bansal B, Srivastava H, Khatri N. A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin [Internet]. IP Indian J Clin Exp Dermatol. 2025 [cited 2025 Oct 02];11(3):372-378. Available from: https://doi.org/10.18231/j.ijced.67329.1758875654
APA
Singh, A., Saxena, K., Kalawat, R., ., K., Bansal, B., Srivastava, H., Khatri, N. (2025). A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin. IP Indian J Clin Exp Dermatol, 11(3), 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654
MLA
Singh, Amarjeet, Saxena, Kshitij, Kalawat, Riya, ., Ketki, Bansal, Bhavika, Srivastava, Hansa, Khatri, Nidhi. "A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin." IP Indian J Clin Exp Dermatol, vol. 11, no. 3, 2025, pp. 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654
Chicago
Singh, A., Saxena, K., Kalawat, R., ., K., Bansal, B., Srivastava, H., Khatri, N.. "A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin." IP Indian J Clin Exp Dermatol 11, no. 3 (2025): 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654